C&R Research Inc
359090
Company Profile
Business description
C&R Research Inc provides a quotation on clinical trial service. The company is a contract research organization specializing in clinical trial design, consulting, monitoring, data management, and licensing for clients like pharmaceutical companies and biotech ventures.
Contact
412 Yeoksam-ro
C&R Building
Gangnam-gu
Seoul
KORT: +82 262511500
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
526
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,149.20 | 24.10 | 0.26% |
| CAC 40 | 8,263.87 | 355.13 | 4.49% |
| DAX 40 | 24,080.63 | 1,159.04 | 5.06% |
| Dow JONES (US) | 47,909.92 | 1,325.46 | 2.85% |
| FTSE 100 | 10,608.88 | 260.09 | 2.51% |
| HKSE | 25,808.00 | 85.02 | -0.33% |
| NASDAQ | 22,634.99 | 617.14 | 2.80% |
| Nikkei 225 | 55,861.55 | 446.87 | -0.79% |
| NZX 50 Index | 13,278.48 | 24.54 | 0.19% |
| S&P 500 | 6,782.81 | 165.96 | 2.51% |
| S&P/ASX 200 | 8,949.70 | 34.30 | 0.38% |
| SSE Composite Index | 3,965.70 | 29.30 | -0.73% |